| Vinblastine studied in …STUDIED_INderived141 of 141show fewer |
|---|
| → studied in | NCT04628767Phase 2/Phase 3 · recruiting Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer · 141 trials list this drug (29 active) | — | — | Renal Pelvis and Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05675410Phase 3 · recruiting A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab · 141 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03585465Phase 1/Phase 2 · terminated Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors · 141 trials list this drug (29 active) | — | — | Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233347Phase 2 · active not recruiting Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03407144Phase 2 · active not recruiting Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667) · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03517137Phase 2 · active not recruiting Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06745076Phase 2 · recruiting Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma,Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07551583Phase 2 · recruiting Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05180825Phase 2 · recruiting Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy · 141 trials list this drug (29 active) | — | — | Pleomorphic Xanthoastrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05137262Phase 2 · active not recruiting A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder · 141 trials list this drug (29 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907488Phase 3 · active not recruiting Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Classic Hodgkin Lymphoma,Lymphocyte-Rich Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06960577Phase 3 · recruiting Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2) · 141 trials list this drug (29 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06164275Phase 2 · active not recruiting Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04685616Phase 3 · recruiting Brentuximab Vedotin in Early Stage Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04576117Phase 3 · active not recruiting A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma · 141 trials list this drug (29 active) | — | — | Low Grade Glioma,Low Grade Astrocytoma,WHO Grade 1 Glioma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03755804Phase 2 · active not recruiting Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01868451NA · completed Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01476410Phase 2 · completed Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Adult Hodgkin Lymphoma,Adult Mixed Cellularity Classic Hodgkin Lymphoma,Adult Nodular Sclerosis Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02710734Phase 2 · completed Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) · 141 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07013565Phase 2 · recruiting Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL · 141 trials list this drug (29 active) | — | — | Anaplastic Large Cell Lymphoma, ALK-Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06204614early Phase 1 · enrolling by invitation Drug Screening Using IMD in Bladder Cancer · 141 trials list this drug (29 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05404945Phase 2 · active not recruiting Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above · 141 trials list this drug (29 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06377566Phase 2 · recruiting A Study of BV-AVD in People With Bulky Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01712490Phase 3 · completed A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06831370Phase 4 · recruiting A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03033914Phase 1/Phase 2 · active not recruiting A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL) · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06984146Phase 2 · recruiting Nivo40-AVD for Advanced Classic Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Adult Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02979522Phase 1/Phase 2 · active not recruiting A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04383743Phase 2 · completed Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer · 141 trials list this drug (29 active) | — | — | Malignant Bladder Neoplasm,Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03646123Phase 2 · terminated Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01771107Phase 1/Phase 2 · completed Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | AIDS-Related Hodgkin Lymphoma,Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03159897Phase 3 · completed FIL Study on ABVD DD-DI as Upfront Therapy in HL. · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002462Phase 3 · active not recruiting RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005584Phase 3 · active not recruiting Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049595Phase 3 · completed Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00379041Phase 3 · active not recruiting Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03331341Phase 1/Phase 2 · completed Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05008224Phase 2 · completed Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) · 141 trials list this drug (29 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06381570early Phase 1 · recruiting Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas · 141 trials list this drug (29 active) | — | — | Low Grade Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03004833Phase 2 · completed Nivolumab and AVD in Early-stage Unfavorable Classical Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03712202Phase 2 · active not recruiting Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Classic Hodgkin Lymphoma,Lymphocyte-Rich Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04638790Phase 3 · recruiting First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1) · 141 trials list this drug (29 active) | — | — | Adult Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02177695Phase 2 · completed S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer · 141 trials list this drug (29 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00678327Phase 3 · completed Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02840409Phase 2 · unknown Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG) · 141 trials list this drug (29 active) | — | — | Low Grade Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01088750Phase 4 · completed Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02181738Phase 2 · completed Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational) · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352027Phase 2 · completed Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03912818Phase 2 · terminated Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer · 141 trials list this drug (29 active) | — | — | Bladder Squamous Cell Carcinoma,Bladder Urothelial Carcinoma,Invasive Bladder Giant Cell Urothelial Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02343718Phase 1 · completed Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours · 141 trials list this drug (29 active) | — | — | Solid Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02412670Phase 2 · completed Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer · 141 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003389Phase 3 · completed Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01390584Phase 2 · terminated Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003027Phase 3 · completed Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma · 141 trials list this drug (29 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003376Phase 3 · completed Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium · 141 trials list this drug (29 active) | — | — | Malignant Bladder Neoplasm,Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003701Phase 3 · completed Combination Chemotherapy in Treating Patients With Bladder Cancer · 141 trials list this drug (29 active) | — | — | Malignant Bladder Neoplasm,Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03226249Phase 2 · unknown PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Classic Hodgkin Lymphoma,Nodular Sclerosis Classical Hodgkin Lymphoma,Lymphocyte-Rich Classical Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01700946Phase 2 · completed Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma · 141 trials list this drug (29 active) | — | — | Childhood B Acute Lymphoblastic Leukemia,Childhood B Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02292979Phase 2 · completed Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma. · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00822120Phase 2 · completed S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006455Phase 3 · completed Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99) · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01887522Phase 2 · terminated Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults · 141 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01884922Phase 1 · completed Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults · 141 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00000626Phase 2 · completed Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132807Phase 2 · completed Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002566Phase 3 · completed Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors · 141 trials list this drug (29 active) | — | — | Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02414568Phase 2 · completed Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin · 141 trials list this drug (29 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030654Phase 3 · completed Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer · 141 trials list this drug (29 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002715Phase 2 · completed Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00498979Phase 1 · completed Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers · 141 trials list this drug (29 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002561Phase 3 · completed Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00398554Phase 2 · completed Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00654732Phase 2 · completed Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01196416Phase 1/Phase 2 · completed Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma · 141 trials list this drug (29 active) | — | — | Melanoma,Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03527628Phase 2 · unknown OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma,Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03092986Phase 4 · completed Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer · 141 trials list this drug (29 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061893Phase 2 · completed Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors · 141 trials list this drug (29 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01542255Phase 2 · terminated Metronomic Therapy in Patients With Metastatic Melanoma · 141 trials list this drug (29 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002855Phase 3 · completed Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer · 141 trials list this drug (29 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038558Phase 3 · completed Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00369681Phase 2 · completed Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030264Phase 2 · completed Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas · 141 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01056679Phase 1 · completed Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma Patients · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00575796Phase 2 · unknown Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs) · 141 trials list this drug (29 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005047Phase 3 · terminated 4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer · 141 trials list this drug (29 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079105Phase 2 · completed A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002495Phase 3 · completed SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00808639Phase 2 · completed Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma · 141 trials list this drug (29 active) | — | — | Bladder Neoplasm,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028756Phase 3 · completed Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium · 141 trials list this drug (29 active) | — | — | Bladder Neoplasm,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072215Phase 3 · terminated Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors · 141 trials list this drug (29 active) | — | — | Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00086801Phase 2 · completed Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00506155Phase 2 · completed Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer · 141 trials list this drug (29 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00024167Phase 3 · terminated Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer · 141 trials list this drug (29 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00512980Phase 2 · terminated PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00635726Phase 2 · terminated Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer · 141 trials list this drug (29 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00317408NA · unknown Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01251107Phase 3 · completed Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01134861Phase 3 · completed Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer · 141 trials list this drug (29 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006237Phase 3 · completed S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma · 141 trials list this drug (29 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01060904Phase 1 · completed A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00213278Phase 2 · completed Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma · 141 trials list this drug (29 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00520403Phase 2 · completed A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer. · 141 trials list this drug (29 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00059839Phase 3 · completed Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00225173Phase 2 · terminated Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003019Phase 2 · completed Vinblastine and Methotrexate in Treating Children With Desmoid Tumors · 141 trials list this drug (29 active) | — | — | Desmoid Fibromatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004010Phase 2 · completed Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352495Phase 1 · completed Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma · 141 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01639521Phase 2 · withdrawn Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer · 141 trials list this drug (29 active) | — | — | Malignant Bladder Neoplasm,Malignant Ureter Neoplasm,Malignant Urethral Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003240Phase 3 · unknown Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer · 141 trials list this drug (29 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003159Phase 3 · completed Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer · 141 trials list this drug (29 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003181Phase 2 · unknown Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer · 141 trials list this drug (29 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003421Phase 3 · completed Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003262Phase 2 · unknown Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004887Phase 3 · unknown Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery · 141 trials list this drug (29 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00041210Phase 3 · unknown Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002887Phase 1 · unknown Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer · 141 trials list this drug (29 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006212Phase 1 · unknown Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer · 141 trials list this drug (29 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00274950Phase 3 · unknown Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors · 141 trials list this drug (29 active) | — | — | Childhood Germ Cell Tumor,Extragonadal Germ Cell Tumor,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004209Phase 3 · unknown Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer · 141 trials list this drug (29 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025064Phase 2 · unknown Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030459Phase 2 · unknown Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma · 141 trials list this drug (29 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416377NA · unknown Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00417014NA · unknown Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00516750Phase 2 · terminated Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin · 141 trials list this drug (29 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00504504Phase 2 · completed Rituximab and ABVD for Hodgkin's Patients · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002919Phase 2 · completed Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer · 141 trials list this drug (29 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014274Phase 2/Phase 3 · completed Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium · 141 trials list this drug (29 active) | — | — | Malignant Bladder Neoplasm,Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002714Phase 2 · completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002823Phase 3 · completed Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer · 141 trials list this drug (29 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005090Phase 3 · terminated S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease · 141 trials list this drug (29 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003084Phase 2 · completed Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer · 141 trials list this drug (29 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003209Phase 3 · completed Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer · 141 trials list this drug (29 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003640Phase 2 · terminated Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer · 141 trials list this drug (29 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002882Phase 3 · completed Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma · 141 trials list this drug (29 active) | — | — | Malignant Skin Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01468740Phase 2 · unknown Prospective Study on HIV-related Hodgkin Lymphoma · 141 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00264953Phase 3 · completed HD11 for Intermediate Stages · 141 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00265018Phase 3 · completed HD10 for Early Stages · 141 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00083083Phase 2 · unknown Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer · 141 trials list this drug (29 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01148446Phase 3 · completed R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL · 141 trials list this drug (29 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00147875Phase 1/Phase 2 · completed Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma · 141 trials list this drug (29 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001570Phase 1 · completed A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer · 141 trials list this drug (29 active) | — | — | Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |